Ranolazine Exerts Potent Effects on Atrial Electrical Properties and Abbreviates Atrial Fibrillation Duration in the Intact Porcine Heart

Introduction: In vitro studies and ambulatory ECG recordings from the MERLIN TIMI‐36 clinical trial suggest that the novel antianginal agent ranolazine may have the potential to suppress atrial arrhythmias. However, there are no reports of effects of ranolazine on atrial electrophysiologic properties in large intact animals.

[1]  Andrew C. Zygmunt,et al.  Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties , 2004, Circulation.

[2]  Andrew C. Zygmunt,et al.  Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial Fibrillation: Differences in Sodium Channel Inactivation Between Atria and Ventricles and the Role of Ranolazine , 2007, Circulation.

[3]  A. Camm,et al.  Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure , 2009 .

[4]  D. Murdock,et al.  The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation , 2008, Indian pacing and electrophysiology journal.

[5]  S. Nattel,et al.  Ranolazine: Ion‐channel‐blocking actions and in vivo electrophysiological effects , 2004, British journal of pharmacology.

[6]  David E. Haines,et al.  Frequency domain algorithm for quantifying atrial fibrillation organization to increase defibrillation efficacy , 2001, IEEE Transactions on Biomedical Engineering.

[7]  Brian Olshansky,et al.  Interrelationships between the autonomic nervous system and atrial fibrillation. , 2005, Progress in cardiovascular diseases.

[8]  C. Antzelevitch,et al.  Role of Repolarization Restitution in the Development of Coarse and Fine Atrial Fibrillation in the Isolated Canine Right Atria , 2005, Journal of cardiovascular electrophysiology.

[9]  A L Waldo,et al.  A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.

[10]  Omer Berenfeld,et al.  Quantifying activation frequency in atrial fibrillation to establish underlying mechanisms and ablation guidance. , 2007, Heart rhythm.

[11]  Delon Wu,et al.  Intracellular calcium dynamics and acetylcholine-induced triggered activity in the pulmonary veins of dogs with pacing-induced heart failure. , 2008, Heart rhythm.

[12]  Hong Liu,et al.  Rapid and stable re-entry within the pulmonary vein as a mechanism initiating paroxysmal atrial fibrillation. , 2005, Journal of the American College of Cardiology.

[13]  M. Domanski,et al.  Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study , 2004, Circulation.

[14]  R. Lazzara,et al.  Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions. , 2006, Heart rhythm.

[15]  Ralph Lazzara,et al.  Autonomic Mechanism to Explain Complex Fractionated Atrial Electrograms (CFAE) , 2007, Journal of cardiovascular electrophysiology.

[16]  M. Fishbein,et al.  Autonomic nerves in pulmonary veins. , 2007, Heart rhythm.

[17]  Stanley Nattel,et al.  Mechanisms of atrial fibrillation: lessons from animal models. , 2005, Progress in cardiovascular diseases.

[18]  R. Lazzara,et al.  An Acute Model for Atrial Fibrillation Arising from a Peripheral Atrial Site: Evidence for Primary and Secondary Triggers , 2008, Journal of cardiovascular electrophysiology.

[19]  Silvia G. Priori,et al.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .

[20]  Kapil Kumar,et al.  Potent antifibrillatory effects of intrapericardial nitroglycerin in the ischemic porcine heart. , 2003, Journal of the American College of Cardiology.

[21]  José Jalife,et al.  Cholinergic atrial fibrillation: I(K,ACh) gradients determine unequal left/right atrial frequencies and rotor dynamics. , 2003, Cardiovascular research.

[22]  C. Antzelevitch,et al.  Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations. , 2008, Heart rhythm.

[23]  A. Skene,et al.  Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. , 2007, JAMA.

[24]  A. Waldo,et al.  Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial Fibrillation: Differences in Sodium Channel Inactivation Between Atria and Ventricles and the Role of Ranolazine , 2008 .

[25]  Kapil Kumar,et al.  Effect of Ranolazine on Ventricular Vulnerability and Defibrillation Threshold in the Intact Porcine Heart , 2008, Journal of cardiovascular electrophysiology.